Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2017-10-31
2020-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration
NCT03225495
Evaluation of Bone Changes Around Implants in Patients Treated With All on Four
NCT06723678
Stability of the Marginal Bone Around Subcrestal Implants
NCT05494476
Regenerative Therapy of Periodontal Bone Defects
NCT03435653
Effectiveness in Limiting the Need to Elevate the Maxillary Sinus
NCT03357705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In fact, the etiology of this Marginal Bone Loss has not yet been well understood, although many theories have been proposed to explain it.
The influence of the thickness of the mucous membrane on marginal bone loss was discussed elsewhere which suggests a protective action for the underlying soft tissue that recreates a kind of "biological amplitude" around the implant. Some studies have suggested that a marginally oscillating bone loss between 1.5 and 2.0 mm provides the vertical space for proper restoration of the biological amplitude. Some authors. published a study that demonstrated that, in crestal systems with switching platforms, a vertical thickness of soft tissue greater than 2 mm is effective in preventing periimplant crestal bone loss. However, the severity of the sample examined precludes the possibility of making definitive conclusions.
Recently other authors have shown significant marginal bone loss around implants with lower prosthetic implants than those with higher prosthetic prostheses, without however measuring the thickness of soft tissues and evaluating their influence. In particular, the extent of bone loss was extremely limited when the height of the stump was equal to or greater than 2 mm. From a theoretical point of view, a prosthetic abutment of at least 2 mm high, calculated from the apical margin of the crown to the platform of the implant, should provide adequate space for restoring the biological amplitude.
It can therefore be hypothesized that these two factors (the vertical thickness of soft tissues and the height of the prosthetic stump) are the expression of the same principle: the restoration of the biological amplitude around the implant's neck. From a clinical point of view it will be useful to determine which of the two factors is most important in preventing and limiting periimplant bone loss.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
maxillary total edentulism
all on four implant rehabilitation with trans-sinusal implants
all on four implant rehabilitation
implant insertion after piezoelectric site preparation for trans-sinusal implants
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
all on four implant rehabilitation
implant insertion after piezoelectric site preparation for trans-sinusal implants
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. presence of a residual bone crest with a minimum surgical height of 4 mm at the maxillary sinus (bilaterally), and a thickness of at least 6 mm at the two distally programmed implant sites;
3. presence of a residual bone crest with a minimum surgical height of 10 mm at the anterior maxilla, and a thickness of at least 6 mm at the mesially programmed implant sites;
4. the bone crest should be healed (at least 6 months after the loss / extraction of the corresponding dental element);
5. no regenerated bone;
6. Plaque index below 25% and bleeding index less than 20%;
7. the buccal length of the adherent gingiva ≥ 4 mm;
8. age of the patient\> 18 years;
9. systemic condition of the compensated patient (American Society of Anesthesiologist score \< 2);
8\) Patients should be able to examine and understand the protocol of study; 9) subscribing to informed consent.
Exclusion Criteria
2. cardiovascular disease
3. incapability of maintaining a good oral hygiene
19 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Piezosurgery Academy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mr. Claudio Stacchi, DDS, MSc
President of the International Piezosurgery Academy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio Stacchi, Dr
Role: STUDY_DIRECTOR
International Piezosurgery Academy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Piezosurgery Academy
Parma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Malo P, Rangert B, Nobre M. "All-on-Four" immediate-function concept with Branemark System implants for completely edentulous mandibles: a retrospective clinical study. Clin Implant Dent Relat Res. 2003;5 Suppl 1:2-9. doi: 10.1111/j.1708-8208.2003.tb00010.x.
Agliardi EL, Tete S, Romeo D, Malchiodi L, Gherlone E. Immediate function of partial fixed rehabilitation with axial and tilted implants having intrasinus insertion. J Craniofac Surg. 2014 May;25(3):851-5. doi: 10.1097/SCS.0000000000000959.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nobelsinus
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.